Company Filing History:
2 out of 491 
1 out of 104 
Years Active: 2009-2010
Title: Innovations of Nathalie Vanderheijden: Exploring the Mechanisms of PRRS Virus Entry
Introduction: Nathalie Vanderheijden, an accomplished inventor residing in Merelbeke, Belgium, has made significant contributions in the field of biotechnology. With two patents to her name, her work focuses on understanding and addressing viral challenges in cellular environments, particularly regarding the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).
Latest Patents: Vanderheijden's most recent patent revolves around a nucleic acid encoding a polypeptide involved in the cellular entrance of the PRRS virus. This innovation describes a new polynucleotide that encodes a polypeptide critical for the virus's entry into cells. The patent details a recombinant vector that includes the polynucleotide, methods for producing the polypeptide, and identifying compounds that affect the PRRSV receptor function of the polypeptide. The invention is notable for isolating a protein from PAM membranes that plays a vital role in virus entry. This research revealed a significant homology between the putative PRRSV receptor and certain proteins belonging to the Siglec family.
Career Highlights: Nathalie Vanderheijden has established her scientific career through rigorous research and development. Holding two patents, she has contributed essential knowledge in viral pathogenesis and cell biology. Her innovations reflect her dedication to enhancing understanding that may lead to therapeutic advancements in combating viral infections.
Collaborations: Throughout her career, Vanderheijden has worked alongside esteemed colleagues, including Maurice Pensaert and Hans Nauwynck. Her collaborations have enabled her to combine expertise and broaden the impact of her research. Additionally, she has been associated with notable institutions such as Ghent University and Intervet International B.V., further showcasing her engagement in exemplary scientific communities.
Conclusion: Nathalie Vanderheijden represents an inspiring figure in the world of biotechnological innovations. Her ongoing research into viral mechanisms and the development of novel compounds holds promise for significant advancements in medical science, particularly in addressing diseases like PRRSV. As her career progresses, her contributions will continue to impact both the academic and health sectors, illustrating the vital role of inventors in advancing knowledge and technology.